First patient with advanced breast cancer receives first dose in clinical trial of GlycoMimetics’ GMI-1359

First patient with advanced breast cancer receives first dose in clinical trial of GlycoMimetics’ GMI-1359. (Credit: PublicDomainPictures from Pixabay)